| Bioactivity | HPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2020235902A1 compound 106[1]. |
| Target | hematopoietic progenitor kinase 1 (HPK1) |
| Name | HPK1-IN-20 |
| CAS | 2561490-78-4 |
| Formula | C26H28N6O2 |
| Molar Mass | 456.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hyun JS, et, al. Heterocycle-fused pyrimidine derivative and use thereof. WO2020235902A1. |
HPK1-IN-20
CAS: 2561490-78-4 F: C26H28N6O2 W: 456.54
HPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2020235902A1 compound 106.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.